Farmer, Luc J.,Perni, Robert B.,Bhisetti, Govinda Rao,Wilson, Keith P.
申请号：
AU2012202576
公开号：
AU2012202576A1
申请日:
2012.05.02
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
#$%^&*AU2012202576A120120524.pdf#####ABSTRACT The present invention relates to compounds of formula (I) or a pharmaceutically acceptable salt, or mixtures thereof, that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4 protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are useful as antiviral agents. The invention further relates to pharmaceutically acceptable compositions comprising said compounds either for ex vivo use or for administration to a patient suffering from HCV infection and processes for preparing the compounds. The invention also relates to methods of treating an HCV infection in a patient by administering a pharmaceutical composition comprising a compound of this invention.
